dsm-firmenich issues €1.5 billion long-term bonds

Press Release

dsm-firmenich issues €1.5 billion long-term bonds

Kaiseraugst (Switzerland), Maastricht (Netherlands), February 17 2026

dsm-firmenich today announces the successful launch of a €1.5 billion dual-tranche bond issuance, consisting of:

• €750 million 3.00% fixed-rate notes due 2031
• €750 million 3.75% fixed-rate notes due 2038  

The bonds will be issued by DSM B.V. and guaranteed by DSM-Firmenich AG pursuant to the previously established .

The proceeds of the new bonds will be used for refinancing of existing bond maturities.

The terms are laid down in the €8 billion Debt Issuance Program of dsm-firmenich alongside the Final Terms of this issuance, both of which are available .

The re-offer price for the 5-year bond tranche was 99.886%. Based on this price, the yield is 3.025%.

The re-offer price for the 12-year bond tranche was 99.100%. Based on this price, the yield is 3.845%.

The bonds will shortly be listed on the Luxembourg Stock Exchange.

DSM-Firmenich AG is rated A3 (stable outlook) by Moody’s and A- (stable outlook) by S&P.

For more information, please contact:

dsm-firmenich investor relations enquiries:

Email:

dsm-firmenich media enquiries:

Email:   

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for people and the planet. dsm-firmenich is a Swiss company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.  

Disclaimer  

This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This communication is not for release, distribution or publication, whether directly or indirectly and whether in whole or in part, into or in the United States of America or any (other) jurisdiction where any of such activities would constitute a violation of the relevant laws of such jurisdiction.

The offer of bonds referred to in this communication was limited in the EEA and the United Kingdom to qualified investors only. The bonds have not been and will not be registered under the US Securities Act of 1933, as amended (the “US Securities Act”) and will also not be registered with any authority competent with respect to securities in any state or other jurisdiction of the United States of America. The bonds may not be offered or sold in the United States of America without either registration of the securities or an exemption from registration under the US Securities Act being applicable.

The English language version of this press release prevails over other language versions.

Attachment